The decline in numbers of healthcare professionals (HCPs) willing to contribute to market research could have a detrimental effect on the quality of data provided to pharma. John Aitchison reports on why fewer are willing to join in and offers five changes that need to be made to improve uptake.
Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care" drug for the common skin disorder.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.